Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016

Global IVD products market: 4% CAGR growth expected between 2012-2016


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-02-12 05:37:02 - Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016 - a new market research report on companiesandmarkets.com

The Global IVD Products market is to grow at a CAGR of 4.33 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth of the IVD market in emerging countries. The market has also been witnessing a significant increase in the number of acquisitions of small and medium companies. However, the emergence of counterfeit or duplicate IVD products could pose a challenge to the growth of this market.

Since the recession of 2008?2009, the Global IVD Products and Test market has been witnessing a significant increase in acquisitions by the global vendors. Most of the IVD vendors are acquiring small and medium companies to stay ahead of the competition. For instance, in

 

 

2010, Abbott Laboratories acquired STARLIMS Technology and Alere Inc. Acquired stocks of Axis-Shield plc. In addition, Gen-Probe Inc. Acquired GTI Diagnostics and Warburg Pincus LLC acquired Thoratec Corp. In 2010. These acquisitions by the leading vendors will enable them to develop a variety of offerings for the Global IVD Products and Test market, which is expected to boost their revenue during the forecast period.

One of the major drivers is the increased focus of the leading vendors on emerging countries such as the BRIC countries. One of the major reasons for this increased focus is the significant increase in the growth of chronic diseases in patients in these countries, which is likely to foster a demand for IVD testing.

One of the major challenges is the emergence of counterfeits of the leading brands of IVD products, which are especially common in the Blood Glucose Test Strips segment. These counterfeits are likely to give incorrect blood glucose values, resulting in errors in medication dosages, thus putting patients´ lives at risk.

The key vendors dominating this space include Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, F. Hoffmann-La Roche Ltd., and Siemens Healthcare. The other vendors mentioned in the report are 23andMe Inc., A. Menarini Diagnostics S.r.l., Affymetrix Inc., Agilent Technologies Inc., Alere Inc., ARKRAY Inc., Arrayit Diagnostics Inc, Astra Biotech GmbH, Axis-Shield plc, Beckman Coulter Inc., BG Medicine Inc., Bio-Rad Laboratories Inc., Bruker BioSciences Corp., Caliper Life Sciences Inc., Celera Diagnostics LLC, Cepheid Inc., China Medical Technologies Inc., Dako A/S, Danaher Corp., DiaSorin S.p.A., Eiken Chemical Co. Ltd., ELITech SA, Enzo Biochem Inc., Epigenomics AG, Fujirebio Diagnostics Inc., GE Healthcare, Grifols SA, Horiba Ltd., Idaho Technology Inc., Illumina Inc., Innogenetics NV, Instrumentation Laboratory Company, International Technidyne Corp., Intrinsic Bioprobes Inc., IRIS International Inc., Life Technologies Corp., Linkage Biosciences Inc., Luminex Corp., Magellan Biosciences Inc., Millipore Corp., Mitsubishi Chemical Medience Corp., Nanosphere Inc., Nanosphere Inc., Nova Biomedical Corp., Novartis AG, OPTI Medical Systems Inc., OptiGene Ltd., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Phadia AB, Polymedco Inc., QIAGEN N.V., Quidel Corp., Radient Pharmaceuticals Corp., Radiometer A/S, Randox Laboratories Ltd., Seegene Inc., SensiGen LLC, Sequenom Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Spartan Bioscience Inc., Sysmex Corp., TessArae LLC, Thermo Fisher Scientific Inc., Tosoh Corp., Transasia Bio-Medicals Ltd., Transgenomic Inc., TrimGen Corp., Trinity Biotech plc, TrovaGene Inc., Ventana Medical Systems Inc., Veridex LLC, Vermillion Inc., Wako Pure Chemical Industries Ltd., and Werfen Life Group SA.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser